ConsortiEX

ConsortiEX Inc.Founded in 2013 and headquartered in Milwaukee, US, ConsortiEX Inc. specializes in compliance solutions for the pharmacy sector.6 mn post-money.ConsortiEX specializes in providing comprehensive compliance solutions tailored for the pharmacy sector, particularly in relation to the Drug Supply Chain Security Act (DSCSA) and the Drug Quality and Security Act (DQSA). Their primary offerings include the DSCSA Compliance as a Service, which alleviates the compliance burden from healthcare providers by managing the complexities of drug safety and regulatory adherence. Additionally, the Assure-Trak® Compounding Management System supports both sterile and non-sterile compounding practices while ensuring compliance with multiple regulatory guidelines, including DQSA and various United States Pharmacopeia (USP) standards.ConsortiEX operates on a subscription-based model, where healthcare institutions engage with the company's services to maintain compliance with stringent regulatory standards. The revenue structure is primarily derived from the provision of its flagship products, such as the DSCSA Compliance as a Service and the Assure-Trak® Compounding Management System, which facilitate seamless management of pharmaceutical compliance and operations. Clients, including hospitals and healthcare systems, typically subscribe to these services for ongoing compliance support, allowing for a continuous revenue stream. The company plans to expand its services into new markets, particularly targeting healthcare providers in underserved regions across the US by the end of 2023.

1. Series A

   Sep 10, 2014

   Amount

   $0.9M

   Investors

   Locked